The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s ...

Kepler Capital analyst Justine Telliez maintained a Buy rating on Valneva (0OB3 – Research Report) on September 18 and set a price ...

Nearly half a million Americans received an unpleasant surprise this summer, according to insurance billing data: a new ...

A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.

Valneva is a founding member of Scottish Patient Awareness Council which aims to foster Scottish life sciences growth through united patient empowerment for a healthier future.

Valneva SE (VALN) said that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada ...

A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces the successful pricing of its Private Placement (as defined below) for a final ...

In April, HHS’ Office for Civil Rights issued a final rule that said health providers can’t discriminate against patients by ...

In a recent article, researchers explored the use of MALDI-MS and machine learning to verify vaccine authenticity, offering a ...